Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration

Inflamm Bowel Dis. 2024 Jul 3;30(7):1211-1214. doi: 10.1093/ibd/izad168.
No abstract available

Keywords: clinical trials; drug approval; regulatory agency.

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Drug Approval*
  • Europe
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Time Factors
  • United States
  • United States Food and Drug Administration*

Substances

  • Gastrointestinal Agents